Abstract:Drug-induced cardiotoxicity is a major health concern which can lead to serious adverse effects including life-threatening cardiac arrhythmias via the blockade of the voltage-gated hERG potassium ion channel. It is therefore of tremendous interest to develop advanced methods to identify hERG-active compounds in early stages of drug development, as well as to optimize commercially available drugs for reduced hERG activity. In this work, we present CardioGenAI, a machine learning-based framework for re-engineering both developmental and marketed drugs for reduced hERG activity while preserving their pharmacological activity. The framework incorporates novel state-of-the-art discriminative models for predicting hERG channel activity, as well as activity against the voltage-gated NaV1.5 and CaV1.2 channels due to their potential implications in modulating the arrhythmogenic potential induced by hERG channel blockade. These models can also serve independently as effective components of a virtual screening pipeline. We applied the complete framework to pimozide, an FDA-approved antipsychotic agent that demonstrates high affinity to the hERG channel, and generated 100 refined candidates. Remarkably, among the candidates is fluspirilene, a compound which is of the same class of drugs (diphenylmethanes) as pimozide and therefore has similar pharmacological activity, yet exhibits over 700-fold weaker binding to hERG. We have made all of our software open-source to facilitate integration of the CardioGenAI framework for molecular hypothesis generation into drug discovery workflows.
Abstract:The incredible capabilities of generative artificial intelligence models have inevitably led to their application in the domain of drug discovery. It is therefore of tremendous interest to develop methodologies that enhance the abilities and applicability of these powerful tools. In this work, we present a novel and efficient semi-supervised active learning methodology that allows for the fine-tuning of a generative model with respect to an objective function by strategically operating within a constructed representation of the sample space. In the context of targeted molecular generation, we demonstrate the ability to fine-tune a GPT-based molecular generator with respect to an attractive interaction-based scoring function by strategically operating within a chemical space proxy, thereby maximizing attractive interactions between the generated molecules and a protein target. Importantly, our approach does not require the individual evaluation of all data points that are used for fine-tuning, enabling the incorporation of computationally expensive metrics. We are hopeful that the inherent generality of this methodology ensures that it will remain applicable as this exciting field evolves. To facilitate implementation and reproducibility, we have made all of our software available through the open-source ChemSpaceAL Python package.
Abstract:As the rapidly evolving field of machine learning continues to produce incredibly useful tools and models, the potential for quantum computing to provide speed up for machine learning algorithms is becoming increasingly desirable. In particular, quantum circuits in place of classical convolutional filters for image detection-based tasks are being investigated for the ability to exploit quantum advantage. However, these attempts, referred to as quantum convolutional neural networks (QCNNs), lack the ability to efficiently process data with multiple channels and therefore are limited to relatively simple inputs. In this work, we present a variety of hardware-adaptable quantum circuit ansatzes for use as convolutional kernels, and demonstrate that the quantum neural networks we report outperform existing QCNNs on classification tasks involving multi-channel data. We envision that the ability of these implementations to effectively learn inter-channel information will allow quantum machine learning methods to operate with more complex data. This work is available as open source at https://github.com/anthonysmaldone/QCNN-Multi-Channel-Supervised-Learning.
Abstract:Applying deep learning concepts from image detection and graph theory has greatly advanced protein-ligand binding affinity prediction, a challenge with enormous ramifications for both drug discovery and protein engineering. We build upon these advances by designing a novel deep learning architecture consisting of a 3-dimensional convolutional neural network utilizing channel-wise attention and two graph convolutional networks utilizing attention-based aggregation of node features. HAC-Net (Hybrid Attention-Based Convolutional Neural Network) obtains state-of-the-art results on the PDBbind v.2016 core set, the most widely recognized benchmark in the field. We extensively assess the generalizability of our model using multiple train-test splits, each of which maximizes differences between either protein structures, protein sequences, or ligand extended-connectivity fingerprints. Furthermore, we perform 10-fold cross-validation with a similarity cutoff between SMILES strings of ligands in the training and test sets, and also evaluate the performance of HAC-Net on lower-quality data. We envision that this model can be extended to a broad range of supervised learning problems related to structure-based biomolecular property prediction. All of our software is available as open source at https://github.com/gregory-kyro/HAC-Net/.